
KYC Becomes KYA: Sentinel Bio's Joshua Monrad on DNA Screening, Uplift Studies & Agent Monitoring
Sentinel Bio co-founder and managing director Joshua Monrad joins Nathan Labenz to examine the evolving biosecurity risks posed by frontier artificial intelligence and autonomous agents. Drawing on recent in-lab uplift trials and multimodal troubleshooting benchmarks, Monrad explains how emerging models are rapidly dismantling tacit-knowledge barriers in wet labs. He analyzes potential governance interventions ranging from pathogen training-data filtering to DNA synthesis screening as robotics development looms as the final physical bottleneck. With biological tools advancing toward dual-use democratization, this discussion outlines the critical time horizon left to establish robust defense regimes. For full show notes, links, and references, read the episode page:https://www.cognitiverevolution.ai/kyc-becomes-kya-sentinel-bio-s-joshua-monrad-on-dna-screening-uplift-studies-agent-monitoring/ Sponsors: Lovable: Lovable is the software creation platform that brings your ideas to life with enterprise-grade infrastructure and flexible AI coding agents. Start building your next project today at https://lovable.comVisit https://fruitopia.ai to explore more than 400 fruits, and more than 8000 varieties, from all around the world. Claude: Claude is the AI collaborator built for problem solvers, extending your thinking across coding, modeling, and strategic workflows. Get started and discover Claude Pro at https://claude.ai/tcr OutSystems: OutSystems is the leading agentic systems platform, helping enterprises build, modernize, and operate mission-critical applications at the speed of AI. Learn more and start owning your agentic future at https://outsystems.com/tcr Tasklet: Tasklet empowers your business with AI agents that connect to your tools and automate recurring workflows with no code required. Visit https://tasklet.ai and use code cog rev for $50 in free credits CHAPTERS: (00:00) About the Episode (05:24) Sponsor: Lovable (07:08) Four phases of biorisk (11:57) H